Skip to main content
Equibles

Adam Daney

NovoCure Ltd (NVCR)

Equibles does not estimate personal net worth.

Get an email with a short summary when NovoCure Ltd publishes a filing, an earnings call transcript or a press release.

Get NVCR alerts

About Adam Daney

Adam Daney has spoken on 4 earnings calls across 1 company, most recently for NovoCure Ltd on October 29, 2026. NovoCure Ltd is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at NovoCure Ltd includes Asaf Danziger (CEO and Board Member), David Hung (CEO and Board Member), Frank Leonard (CEO and Board Member) and 7 others.

Adam Daney on recent calls

“Good morning, and thank you for joining us to review Novocure's third quarter 2026 performance. I'm joined on the phone today by our Executive Chairman, Bill Doyle, CEO Frank Leonard, Chief Innovation and Medical Officer Ori Weinberg, and CFO Christoph Brockman.”
Other, Q3 2026 Earnings Conference Call ·
“And thank you for joining us to review Novocure's second quarter 2026 performance. I'm joined on the phone today by our Executive Chairman, Bill Doyle, CEO, Frank Leonard, Chief Innovation and Medical Officer, Ori Weinberg, and CFO, Christoph Brockman.”
Head of Investor Relations, Q2 2026 Earnings Conference Call ·
“Good morning, and thank you for joining us to review NovaCure's first quarter of 2026 financial performance. I'm joined on the phone today with our Executive Chairman Bill Doyle, CEO Frank Leonard, Chief Innovation and Medical Officer Ori Weinberg, and CFO Christoph Brockman.”
Head of Investor Relations, NovoCure Ltd Q1 FY2026 Earnings Call ·
“Good morning, and thank you for joining us to review Novocure's fourth quarter and full year 2025 performance. I'm joined on the phone today with our Executive Chairman Bill Doyle, CEO Frank Leonard, and CFO Christophe Brockman.”
Head of Investor Relations, NovoCure Ltd Q4 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at NovoCure Ltd

Recent activity